Alpha and Omega MedTech (AOM), also trading as Alpha and Omega Medical Group, is South Africa’s Healthcare Innovation Company, based in uMgungundlovu, KwaZulu-Natal. Compliant with Level 1 BBEEE, South African Health Products Regulatory Autority (SAHPRA)  licence 00001895MD, CSD No. MAAA1078777.  Is a United Nations Global Compact Listed Company, Department of Science & Innovation Bridge Portal verified and official Medical Device vendor on CDC Africa and African Union Backed Africa Medical Supplies Platform. AOM operates under 3 main pillars under a NHI Family Medicine “doctor-centric” approach: 1.         Develop and facilitate localizing the manufacturing of “Made in South Africa” Medical Consumables and Products (COVID-19 Rapid Test) 2.         Drive the Investment and Strategy to build Community Diagnostic Centers for the 40+ Million with no private health (uMgungundlovu Medical Hub) 3.         Skills Development and Job Creation for Clinical Researchers (Trained over 100) AOM’s Milestones include:   1.         One of the Largest Private Company Responders to SA’s COVID-19 Crisis During 2021, at the height of the delta wave variant of COVID-19, AOM facilitated a R25 Million Rand Donation of 100,000 Rapid Antibody Test Kits to the South African Medical Research Council, playing their part in the fight against COVID-19 and establishing a credible footprint in SA.   2.         Point of Care Rapid Antigen Test and its merge with digital health tracking using the COVID Alert APP SA and NHLS Results, this Technology was presented at the First International Conference on Public Health in Africa, by CDC Africa. 3.         Recognised as the World’s First China-Africa Healthcare Innovation Platform, with a model for Partnerships, AOM boasts one of the Largest China-Africa Healthcare Teams and has developed the groundbreaking NutriPowder aimed at curbing SSA Malnutrition.